Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer × Denosumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Giant Cell Tumor of Bone 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1

Interventions

pembrolizumab 1 Zoledronic Acid 1 ETC-159 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06513624 2025-07-25

ETC-159-02

National University Hospital, Singapore

Phase 1 Recruiting

With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡